Bay Hematology Oncology

Easton, Maryland 2160l

0 studies enrolling now · 6 studies all time

What they study most

Head and Neck Cancer, Melanoma, Multiple Myeloma, Non Small Cell Lung Cancer (NSCLC), Non-Melanoma Skin Cancers, Non-Small Cell Lung Cancer, Sarcoma, Solid Cancer

Studies at this site

• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide. — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 — Stopped early
• In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® — Completed
• A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) — Stopped early